[ad_1] Updated Jan. 10, 2024 9:45 am ET China has a keen interest in soccer, a population of 1.4 billion people and a powerful leader determined to see his country…
Tag: CSL
CSL to bandage cost pressures to stem bleeding profits
[ad_1] Vaccines and plasma company CSL faces ongoing cost pressures that have hit profits and market value but the underlying performance remains strong, the biomedical leader says. CEO Paul McKenzie,…
CSL Seqirus Announces Third U.S. Government Award in Relation to Influenza A(H5N8) Candidate Vaccine
[ad_1] CSL Seqirus will deliver further H5N8 A/Astrakhan antigen to support the U.S. government’s pandemic preparedness activities This is the third influenza pandemic preparedness award to CSL Seqirus in the…
CSL Vifor
[ad_1] Pioneer in iron-based therapies, CSL Vifor is a global leader in iron deficiency and iron deficiency anaemia therapies, with a history dating back to 1872, when pharmacist Caspar Friedrich…
CSL Seqirus
[ad_1] Derived from the expression ‘securing health for all of us‘, CSL Seqirus has public health protection at its core. This reflects the promise of our parent company CSL, founded…
CSL Behring
[ad_1] CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver…
How CSL went from ‘bloated bureaucracy’ to $145b global behemoth
[ad_1] It’s fair to say that no-one foresaw what would happen next. The market, the commentators and most of the mum and dad investors who would go on to buy…
Global Immunoglobulins Markets, 2021-2022 & 2023-2027 with Takeda Pharmaceutical Company Limited., CSL Ltd., Grifols International SA and Kedrion SpA Dominating
[ad_1] DUBLIN, April 13, 2023 /PRNewswire/ — The “Immunoglobulins: Global Market Outlook” report has been added to ResearchAndMarkets.com’s offering. Research and Markets Logo The global immunoglobulins (IG) market was estimated to…